Home > Back to Publisher > Report Information

Medicated Skin Care in Singapore

Euromonitor International
April 1, 2009
39 Pages - SKU: EP2386885

Abstract Table of Contents Search inside this report Related Reports

Euromonitor International's Medicated Skin Care in Singapore report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data (2003-2008), allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, distribution or pricing issues. Forecasts to 2013 illustrate how the market is set to change.

Product coverage: acne treatments, antipruritics, topical germicidals/antiseptics, topical allergy remedies/antihistamines, topical antifungals, vaginal antifungals, antiparasitics/lice (head and body) treatments, medicated shampoos, hair loss treatments, lip care treatments, haemorrhoid treatments, child-specific medicated skin care, nappy (diaper) rash treatments

Data coverage: market sizes (historic and forecasts), company shares and brand shares

Why buy this report?

Get a detailed picture of the medicated skin care industry
Identify factors driving change
Understand the competitive environment, the market’s major players and leading brands
Use five-year forecasts to assess how the market is predicted to develop

Euromonitor International

April 2009

Executive Summary

OTC Healthcare Achieves Healthy Growth in 2008

Consumers Are More Health-conscious

International Manufacturers Maintain Their Dominance

Chemists/pharmacies and Parapharmacies/drugstores Remained Strong

OTC Healthcare Expected To Perform Well Over the Forecast Period

Key Trends and Developments

More Consumers Self-medicate for Minor Ailments

Parents Are More Cautious About Their Children's Health Due To An Outbreak of Hand, Foot and Mouth Disease

Traditional Chinese Medicine Retains Its Popularity Amongst Consumers

Manufacturers Continue To Focus on Products for the Ageing Population

Consumers Still Opt for Premium Brands, Despite the Economic Slowdown

Market Indicators

Table 1 Consumer Expenditure on Health Goods and Medical Services 2003-2008

Table 2 Life Expectancy at Birth 2003-2008

Market Data

Table 3 Sales of OTC Healthcare by Sector: Value 2003-2008

Table 4 Sales of OTC Healthcare by Sector: % Value Growth 2003-2008

Table 5 OTC Healthcare Company Shares by Value 2004-2008

Table 6 OTC Healthcare Brand Shares by Value 2005-2008

Table 7 Penetration of Private Label by Sector 2003-2008

Table 8 Sales of OTC Healthcare by Distribution Format: % Analysis 2003-2008

Table 9 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2008

Table 10 Forecast Sales of OTC Healthcare by Sector: Value 2008-2013

Table 11 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2008-2013

Appendix

OTC Registration and Classification

Vitamins & Dietary Supplements Registration and Classification

Self-medication and Preventative Medicine

Generics

Switches

Definitions

Summary 1 Research Sources

Borden Co (pte) Ltd

Strategic Direction

Key Facts

Summary 2 Borden Co Pte Ltd: Key Facts

Company Background

Production

Competitive Positioning

Integrated Contract Manufacturing Pte Ltd

Strategic Direction

Key Facts

Summary 3 Integrated Contract Manufacturing Pte Ltd: Key Facts

Company Background

Production

Competitive Positioning

Summary 4 Integrated Contract Manufacturing Pte Ltd: Competitive Position 2008

Nin Jiom Medicine Mfy (s) Pte Ltd

Strategic Direction

Key Facts

Summary 5 Nin Jiom Medicine Mfy (S) Pte Ltd: Key Facts

Company Background

Production

Competitive Positioning

Summary 6 Nin Jiom Medicine Mfy (S) Pte Ltd: Competitive Position 2008

Zuellig Pharma Pte Ltd

Strategic Direction

Key Facts

Summary 7 Zuellig Pharma Pte Ltd: Key Facts

Company Background

Production

Competitive Positioning

Headlines

Trends

Switches

Competitive Landscape

Prospects

Sector Data

Table 12 Sales of Medicated Skin Care by Subsector: Value 2003-2008

Table 13 Sales of Medicated Skin Care by Subsector: % Value Growth 2003-2008

Table 14 Herbal vs Standard Medicated Skin Care 2003-2008

Table 15 Acne Treatments by Format: % Value Breakdown 2004-2008

Table 16 Medicated Skin Care Company Shares by Value 2004-2008

Table 17 Medicated Skin Care Brand Shares by Value 2005-2008

Table 18 Acne Treatments Brand Shares by Value 2005-2008

Table 19 Hair Loss Treatments Brand Shares by Value 2005-2008

Table 20 Forecast Sales of Medicated Skin Care by Subsector: Value 2008-2013

Table 21 Forecast Sales of Medicated Skin Care by Subsector: % Value Growth 2008-2013

Medicated Skin Care in Singapore

Share this report

Other tasks

Research Assistance

Related Markets

Dermatology Reports

Free Alert Me service